A Case of Myocarditis Presenting With a Hyperechoic Nodule After the First Dose of COVID-19 mRNA Vaccine

Myocarditis and/or pericarditis have been reported as adverse events following coronavirus disease 2019 (COVID-19) messenger RNA vaccination, with most cases occurring within 1 week after the second dose. We report a rare case of myocarditis after the first dose of the BNT162b2 (Pfizer-BioNTech) COV...

Full description

Saved in:
Bibliographic Details
Published inJournal of Korean medical science Vol. 37; no. 16; pp. e131 - 6
Main Authors Park, Seunghwan, You, Jihye
Format Journal Article
LanguageEnglish
Published Korea (South) The Korean Academy of Medical Sciences 25.04.2022
대한의학회
Subjects
Adolescent
BNT162 Vaccine
Case Report
COVID-19
COVID-19 Vaccines - adverse effects
Humans
Male
mRNA Vaccines
Myocarditis - diagnosis
Myocarditis - etiology
RNA, Messenger
Vaccines, Synthetic
의학일반
COVID-19
Myocarditis
mRNA Vaccines
Adolescent
Online AccessGet full text

Cover

More Information
Summary:Myocarditis and/or pericarditis have been reported as adverse events following coronavirus disease 2019 (COVID-19) messenger RNA vaccination, with most cases occurring within 1 week after the second dose. We report a rare case of myocarditis after the first dose of the BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine in a 17-year-old boy. Here, we describe the laboratory, electrocardiographic, and imaging findings of myocarditis.
ISSN:1011-8934
1598-6357
DOI:10.3346/jkms.2022.37.e131